RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PICCA F
Collezione AOU San Luigi di Orbassano

Items : 6

From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment. in International journal of molecular sciences / Int J Mol Sci. 2024 Oct 9;25(19):10823. doi: 10.3390/ijms251910823.

2024
AOU San Luigi di Orbassano

Picca F; Giannotta C; Tao J; Giordanengo L; Munir HMW; Botta V; Merlini A; Mogavero A; Garbo E; Poletto S; Bironzo P; Doronzo G; Novello S; Taulli R; Bersani F;

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2023 May 12;42(1):120. doi: 10.1186/s13046-023-02690-5.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bardelli A; Di Nicolantonio F; Pietrantonio F; Poli V; Monteleone E; Bironzo P; Tabbò F; Benso F; Zambelli V; Listì A; Volante M; Castella B; Rospo G; Negrino C; Oddo D; Russo M; Napoli F; Righi L; Morena D; Picca F; Bersani F; Ponzetto C; Novello S; Scagliotti GV; Taulli R;

Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103966. doi: 10.1016/j.critrevonc.2023.103966. Epub 2023 Mar 15

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Taulli R; Yoshizumi T; Novello S; Seto T; Haratake N; Takenaka T; Tabbò F; Picca F; Bersani F; Bironzo P; Toyokawa G;

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.

2021
AOU Alessandria
AOU San Luigi di Orbassano

Aviles P; Libener R; Leo F; Guerrera F; Sandri A; Comunanza V; Gigliotti C; Bussolino F; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Novello S; Taulli R; Scagliotti GV; Riganti C;

Future perspectives from lung cancer pre-clinical models: new treatments are coming? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2629-2644. doi: 10.21037/tlcr-20-189.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Righi L; Bironzo P; Tabbò F; Morotti A; Picca F; Morena D; Bersani F; Taulli R;

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.

2018
AOU San Luigi di Orbassano

Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; Libener R; Orecchia S; Bironzo P; Comunanza V; Bussolino F; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R; Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; et alii...